Q&A: Health Care Experts on H5 Bird Flu Vaccine Developments
Drug Topics
OCTOBER 25, 2024
As the H5 bird flu outbreak gradually impacts human health in the US, health care experts weighed in on possibilities of a future vaccine.
Fri.Oct 25, 2024
469 
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Fierce Pharma
OCTOBER 25, 2024
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem. | Iterum's Orlynvah was approved by the FDA Friday to treat certain uncomplicated urinary tract infections (uUTIs) in adult women who have limited or no alternative antibacterial treatment options.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
ICYMI: Total Pharmacy October 2024 Issue
Drug Topics
OCTOBER 25, 2024
Don’t miss out on the latest pharmacy insights in the Total Pharmacy October issue.
STAT+: For the behemoth UnitedHealth, a new threat to Medicare profits
STAT
OCTOBER 25, 2024
For the nation’s largest health insurer, the evidence of abuse was stunning and unmistakable: UnitedHealth Group reaped billions from the federal Medicare program by diagnosing patients with serious chronic illnesses, and then delivering no follow-up care. The findings in the federal report reveal that UnitedHealth repeatedly sent clinicians into patients’ homes and pored over their medical charts to add diagnoses for illnesses such as vascular disease, heart failure, and diabetes.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Denosumab Cost Effectiveness Varies in Postmenopausal Osteoporosis | AMCP Nexus 2024
Drug Topics
OCTOBER 25, 2024
The cost effectiveness of biosimilar denosumab for postmenopausal osteoporosis varies significantly based on factors like adherence, subsequent therapies, and treatment duration.
Understanding the Role of Oncology Pharmacists in Academic vs Community Cancer Centers
Pharmacy Times
OCTOBER 25, 2024
Their expertise complements multidisciplinary teams in a variety of clinical settings.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
In the era of GLP-1 drugs, demand for bariatric surgery plunges
STAT
OCTOBER 25, 2024
For people with obesity, surgeries that shrink, reshape, or otherwise alter the anatomy of the stomach have long reigned supreme as the surest way to weight loss. But in the last few years, with the approval of GLP-1 drugs like Wegovy and Zepbound , more and more people are opting for obesity medicines over gold-standard surgical treatments. “On a population level, among a subset of commercially insured individuals, that is the tradeoff that is happening” said Thomas Tsai, th
Addressing Vaccine Hesitancy, Effectiveness Among Patients with HIV | IDWeek 2024
Drug Topics
OCTOBER 25, 2024
Analyzing outcomes from the COVID-19, influenza, and pneumococcal vaccines, researchers explored the effectiveness and patient hesitancy surrounding each vaccine.
STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight
STAT
OCTOBER 25, 2024
A turbulent series of events surrounding the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around how the Food and Drug Administration maintains its list of drug shortages and which sources it relies on, an issue that affects a growing number of Americans. Earlier this month, the FDA declared an end to the shortage of Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, after almost two years.
Pharmacists Advocate for Patients Amid Opioid Crisis and Increased Pharmacy Deserts
Pharmacy Times
OCTOBER 25, 2024
Pharmacists are encouraged to leverage prescription drug monitoring programs connect patients to community-based resources to address the opioid crisis and pharmacy deserts.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Ability to wed: When getting married could mean losing lifesaving medical benefits
STAT
OCTOBER 25, 2024
When Chelsea Smith met Jason Martin she knew right away that he was the one — so she refused to get his phone number. That’s because getting married would make Smith ineligible for Social Security benefits and Medicaid — financial support that she and many others with disabilities need to survive. Smith didn’t want to risk falling in love knowing she couldn’t get married.
Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide
Pharmacy Times
OCTOBER 25, 2024
The call follows the FDA’s sudden removal of tirzepatide from the drug shortage list, preventing compounding pharmacies from providing the drug.
100M people impacted by massive Change Healthcare cyberattack: OCR
Fierce Healthcare
OCTOBER 25, 2024
UnitedHealth Group has officially disclosed that 100 million people were affected by the massive cyberattack on Change Healthcare earlier this year. | UnitedHealth Group has officially disclosed that 100 million people were affected by the massive cyberattack on Change Healthcare earlier this year.
FDA Approves Oral Sulopenem Etzadroxil and Probenecid for Uncomplicated Urinary Tract Infections
Pharmacy Times
OCTOBER 25, 2024
Orlynvah is approved for uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Being a patient can be a full-time job. This ICU nurse wants to make it easier
STAT
OCTOBER 25, 2024
Michael Anne Kyle had just begun her Ph.D. in health policy and management at Harvard Business School when her friends started complaining about the health care system. Many of them were having children for the first time, and they’d never been to the doctor so much in their lives. They’d text Kyle, who is also an ICU nurse, with gripes.
FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a
Pharmacy Times
OCTOBER 25, 2024
Congenital muscular dystrophy type 1a is a severe, early-onset condition that currently has no treatment, but MDL-101 may serve as a 1-time, durable treatment option.
HCA bracing for $200M hurricane-related financial hit in Q4
Fierce Healthcare
OCTOBER 25, 2024
HCA Healthcare took a $50 million financial hit in the third quarter due to the impacts of the back-to-back hurricanes Helene and Milton, which slammed facilities in North Carolina, Georgia and Flo | HCA Healthcare took a $50 million financial hit in the third quarter due to the impacts of the back-to-back hurricanes Helene and Milton, which slammed facilities in North Carolina, Georgia and Florida.
Cancer Disparities in Rural Areas: The Impact of Social Determinants of Health and Access Challenges
Pharmacy Times
OCTOBER 25, 2024
Nathan Vanderford, PhD, MBA speaks about barriers to cancer care access experienced by patients in rural communities.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma companies must adapt to keep pace with AI developments, say experts
Pharmaceutical Technology
OCTOBER 25, 2024
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.
Study: Increase of Vitamin C Deficiency Associated With Cost of Living and Upsurge of Bariatric Surgery
Pharmacy Times
OCTOBER 25, 2024
Findings highlight the need for health care providers to continue to educate patients on the risk of scurvy, ensuring proper vitamin C intake.
Centene shares rise as it beats the Street on profit, revenue
Fierce Healthcare
OCTOBER 25, 2024
Shares in Centene were up premarket Friday after the company beat Wall Street analysts' expectations on both profit and revenue for the third quarter. | Shares in Centene were up premarket Friday after the company beat Wall Street analysts' expectations on both profit and revenue for the third quarter.
FDA Approves Estradiol Gel, 0.06% for Women Post-Menopause
Pharmacy Times
OCTOBER 25, 2024
In postmenopausal women, the gel can reduce moderate to severe hot flashes as well as menopausal changes and symptoms.
GSK plans $800m US manufacturing investment
pharmaphorum
OCTOBER 25, 2024
GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.The programme represents the largest capital spend by the UK drugmaker on production capacity to date and will double the size and capacity of GSK's existing medicines and vaccines facility in Marietta, Pennsylvania, creating around 200 new jobs.
Ribociclib Recognized by NCCN Clinical Practice Guidelines as Category 1 Preferred Breast Cancer Adjuvant Treatment
Pharmacy Times
OCTOBER 25, 2024
NCCN recommends ribociclib as a preferred CDK4/6 inhibitor adjuvant therapy for patients with HR+/HER2- EBC in combination with an aromatase inhibitor.
Intellia trumpets CRISPR drug data, but shares fall
pharmaphorum
OCTOBER 25, 2024
Intellia reports a big reduction in hereditary angioedema attacks in patients treated with its one-shot CRISPR drug, but its share fall sharply
STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight
STAT
OCTOBER 25, 2024
A turbulent series of events surrounding the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around how the Food and Drug Administration maintains its list of drug shortages and which sources it relies on, an issue that affects a growing number of Americans. Earlier this month, the FDA declared an end to the shortage of Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, after almost two years.
MSD buys Modifi for $1.3bn to boost oncology pipeline
pharmaphorum
OCTOBER 25, 2024
MSD buys Modifi Bio in a $1.3bn deal, getting rights to a new class of drugs for difficult-to-treat cancers, including glioblastoma.
Opinion: Louisiana’s creative new ways to fight maternal mortality
STAT
OCTOBER 25, 2024
You don’t have to be a public health professional to know that the U.S. has the highest maternal mortality rate of any high-income country. It’s chilling, sobering, and unacceptable. The situation is particularly dire for Black women, who are four times more likely to die than white women. Conditions are worse in Southern states.
J&J’s comeback kid Spravato heads for blockbuster status
PharmaVoice
OCTOBER 25, 2024
After a slow start, the novel esketamine nasal spray for depression is now J&J’s fastest-growing medication.
Morning Rounds: Newborn screenings, radiation-proof tardigrades
STAT
OCTOBER 25, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Fun fact: My Ph.D. dissertation was about destroying toxic “forever chemicals,” aka PFAS. This mostly means I am cursed with knowing too much about where these chemicals are used.
GSK pumps up to $800m for US manufacturing site upgrade
Pharmaceutical Technology
OCTOBER 25, 2024
A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.
Trial highlights potential next-gen biologic for lung cancer
European Pharmaceutical Review
OCTOBER 25, 2024
New clinical data has shown a potential best-in-class next-generation antibody-drug conjugate (ADC) can offer promising response rates in extensive-stage small cell lung cancer. The biologic ZL-1310 is being investigated in an ongoing Phase Ia/Ib study in these patients who have had at least one platinum-based chemotherapy regimen. Overall response rate was 74 percent in individuals with at least one post-treatment evaluation.
Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy
Pharmacy Times
OCTOBER 25, 2024
Zaltenibart could be an effective treatment option for C3 glomerulopathy as the most proximal inhibitor of the alternative pathway.
Let's personalize your content